Notice ID: 045b96c3de534259ba9acabb87bda210Combined Synopsis/Solicitation
Acquisition of a Medical Air Supply for the NIDDK Metabolic Suites
Archived on July 26, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- June 28, 2023
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 334519: Other Measuring and Controlling Device Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NICHD
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- NICHD-23-234
- Notice ID
- 045b96c3de534259ba9acabb87bda210
Description
The objective of this requirement is to establish a medical air system for the Metabolic Suites independent from the current Building 10 Clinical Center system.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
NICHD-23-234- Combined Synopsis
- Combined SynopsisCurrentJun 28, 2023
Acquisition of a Medical Air Supply for the NIDDK Metabolic Suites
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. High Temperature Furnace and Grips The National Aeronautics and Space Administration (NASA), Glenn Research Center (GRC) has a requirement for a 1500°C high temperature furnace and fully reversed fatigue rated grips to be used for testing of metallic and composite samples on an existing MTS 810 servo-hydraulic test frame. Specifically, the furnace and grips must meet the minimum requirements: One 1500°C High Temperature Furnace and specifications consisting of the following: Three zone hybrid furnace: MoSi2 center zone and kanthal top and bottom zones Must be capable of achieving specimen temperatures from 700°C to 1500°C Must heat to 1500°C from room temperature in less than 3 hours Clamshell design that opens wide to maximize accessibility for specimen and grip installation Must easily return to test (closed) position to maintain repeatability between tests Must be designed to accommodate MTS and other high-temperature axial extensometers Must have dual extensometer ports with interchangeable inserts Must have dual thermocouple ports with interchangeable inserts Ridid column mounting design to minimize vibration induced disturbances Temperature controller Must include furnace mounting hardware to existing MTS 810 load frame with 2.5” diameter columns with a center to center column spacing of 23.5” 1500°C High Temperature Grips and specifications consisting of the following: Must be engineered to work with 1500°C furnace to enable precise control of thermal gradients Thermal shielding and integral cooling must enable grip to work at temperatures to 1500°C and reduce overall thermal gradient while protecting the grip materials from excessive temperature (over 1000°C) enabling long life performance This grip must be provided with ceramic heat shields for improved durability Allow for specimen temperatures up to 1500°C Less than 1% thermal gradient over the specimen gage length Rated at 25kN for round specimens Rated at 4-7kN for flat specimens Must maintain constant preload on specimen through test loading Must maintain accurate alignment and low bending strains Must achieve less than 5% bending strain on a representative test specimen Must include integrated grip over temperature protection Must include air colling assembly Must include water cooling assembly Must include flat specimen interfaces (includes chamber and piston rod): wedge set, high temp 0-.188 (0-4.77mm) Must include threaded round specimen interfaces (includes chamber and piston rod): ¼-28 and ½-20 threaded adapters Specimen geometry should have a max overall length of 150 mm with 28 mm threaded length at each end Must be capable of 5 Hz or more fully reversed loading Must interface with 1”-14 threads on existing MTS 810 load frame Includes one week on site installation and training. Delivery 9 months after receipt of order. NAICS is 334519. NASA intends to award a Firm-Fixed-Price sole source contract under the authority of FAR 6.302-1 – Only One Responsible Source to: MTS Systems Corporation, 14000 Technology Drive, Eden Prairie, MN 55344-2290 The Government intends to acquire a commercial item using FAR Part 12. Interested organizations may submit their capabilities statements to perform the effort electronically via email to Matthew Sivic at matthew.sivic@nasa.gov no later than 1:00 pm EST on November 22, 2026. The capabilities statement must be submitted in either Word or PDF and must contain clear and convincing evidence that competition for this requirement would be advantageous to the Government. This notice does not constitute a solicitation and any cost associated with preparation and submission of data or any other cost incurred in response to this announcement are the sole responsibility of the respondent and will not be reimbursed by the Government. Such capabilities/qualifications will be evaluated solely for the purpose of determining whether or not to conduct this acquisition on a competitive basis. A determination by the Government not to compete this acquisition on a full and open competition basis, based upon responses to this notice, is solely within the discretion of the Government. NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf | 49% | Special Notice | 11/22/2026 |
The primary purpose of this requirement is to provide support for the quantitative and technical analysis of the chemical constituents of fruit fly lures and attractants. The objectives are as follows: Provide chemical data, analysis and recommendations to assure trap and lure contract performance and quality assurance. Provide chemical data for the development of new fruit fly detection tools and strategies for continued program improvement. Participate in contract Statement of Work criteria development for new contracts awarded to lure manufacturers. | 42% | Pre-Solicitation | 11/25/2026 |
The Meteorology Branch at White Sands Missile Range (WSMR) requires the procurement of a Scintillometer and required supplies which are fully detailed in the attached Product Description. If you are proposing an equivalent product, please provide adequate documentation supporting the salient characteristics which meet the requirement. | 40% | Combined Synopsis | 11/03/2026 |
1. Disclaimer THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice is issued solely for information and market research planning purposes. It does not constitute a Request for Quotation (RFQ), Request for Proposal (RFP), or Invitation for Bids (IFB), nor does it restrict the Government to a particular acquisition approach. No contract or purchase order will be awarded from this announcement, and the Government will not reimburse respondents for any costs incurred in preparing a response. 2. Background and Purpose The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions,, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Section of Cell Cycle Regulation, has a requirement for a Brand-Name Lonza 4D-Nucleofector® System consisting of the following: 4D-Nucleofector Core Unit, Part No. AAF-1003B – Quantity (1) EA 4D-Nucleofector X Unit, Part No. AAF-1003X - Quantity (1) EA 3. One-year warranty extension for each unit. Or a functional domestic equivalent, to support ongoing NIH-funded research involving the genetic manipulation of mammalian cells. Because NICHD's ongoing studies rely on previously validated electroporation pulse-code workflows, experimental protocols, and Nucleocuvette™ consumables established on a prior-generation Lonza Nucleofector platform, the Lonza 4D-Nucleofector® System is the primary known platform capable of ensuring experimental reproducibility and data continuity without requiring costly and time-consuming protocol re-optimization or re-validation. The Office of Acquisitions is conducting market research to identify qualified vendors—including small businesses, authorized distributors, and domestic manufacturers—and specifically seeks market information to determine: 1. Authorized Lonza Sources: The availability of Lonza Walkersville, Inc. or authorized distributors/resellers (including small businesses, HUBZone, 8(a), SDVOSB, WOSB, and Small Disadvantaged Businesses under NAICS 334516) capable of supplying new Lonza equipment with full manufacturer-backed warranties. 2. Buy American Act (FAR Part 25) Compliance: The availability of any domestic end products manufactured in the United States capable of meeting all functional, warranty, training, and legacy workflow-continuity requirements outlined in Section 3 without requiring experimental re-validation. 3. Technical Requirements and Salient Characteristics To meet the Government's minimum requirements, the proposed system must satisfy all functional and technical specifications from the Statement of Work alongside the laboratory's workflow-continuity constraints: Core Control Unit: The system shall include a Lonza 4D-Nucleofector® Core Unit (or a domestic equivalent central control unit) capable of controlling and operating advanced electroporation-based transfection protocols. Small-Volume Transfection Module: The system shall include a Lonza 4D-Nucleofector® X Unit (or a domestic equivalent functional module) capable of processing small-volume samples (specifically ranging from 20 µL to 100 µL) and supporting transfection of primary cells and other difficult-to-transfect cell types. Nucleic Acid & Reagent Delivery: The system shall support delivery of plasmid DNA, RNA, siRNA, CRISPR/Cas9 reagents, and other nucleic acid-based materials into mammalian cells. Optimized Transfection Performance: The system shall provide optimized electroporation programs designed to maximize transfection efficiency while maintaining high post-transfection cell viability. Sensitive Cell Applications: The system shall support research applications involving primary cells, stem cells, immune cells, and other sensitive cell populations that are not efficiently transfected using conventional lipid-based methods. Software and Protocols: The system shall include manufacturer-provided software and protocols necessary for operation of the instrument. Warranty Coverage: The system shall include a minimum one-year manufacturer warranty and one-year warranty extension coverage for both the Core Unit and X Unit (two years total coverage). Warranty coverage shall begin upon Government acceptance of the equipment and continue in accordance with the manufacturer's warranty terms. Consumable & Legacy Protocol Continuity: If proposing Lonza equipment, the system shall be 100% compatible with commercially available Lonza Nucleofector® reagents, Nucleocuvette™ consumables, and existing pulse-code workflows previously developed and validated on a prior-generation Lonza Nucleofector platform. If proposing a domestic alternative, the vendor must demonstrate that its system and consumables achieve equivalent transfection efficiency and post-transfection cell viability across NICHD's existing mammalian cell workflows without requiring protocol re-optimization or experimental re-validation. Delivery, Installation, and Training: Equipment must be delivered to NIH Bethesda (Building 49) and installed, with on-site or virtual user training for up to five (5) NIH personnel completed within 30 days of installation (covering system operation, software functionality, routine maintenance, and basic troubleshooting). All delivery, installation, and training shall be completed within the 12-month period of performance from award. 4. Capability Statement Submission Instructions Interested organizations that believe they can meet all requirements outlined in Section 3 are invited to submit a tailored Capability Statement (no more than 5 pages) containing the following information: 1. Company Profile: Organization name, mailing address, primary Point of Contact (name, title, email, and telephone number), SAM.gov Unique Entity ID (UEI), and CAGE code. 2. Business Size & Socioeconomic Status: Business size under NAICS 334516 (1,000-employee size standard) and applicable socioeconomic designations (e.g., Small Business, Woman-Owned, Veteran-Owned, Service-Disabled Veteran-Owned, HUBZone, 8(a)). 3. Contract Vehicles: Identification of any existing federal contract vehicles held by the vendor through which this equipment can be ordered (e.g., GSA Multiple Award Schedule), or confirmation of open-market availability. 4. Country of Origin (COO): Explicit identification of the manufacturing country of origin for all proposed hardware components and confirmation of whether the system qualifies as a domestic end product under the Buy American Act (FAR Part 25). 5. Technical Capability & Authorization: Product brochures, technical specifications, and catalog numbers demonstrating compliance with every requirement in Section 3. If proposing Lonza equipment: Documentation confirming status as an Authorized Distributor/Reseller eligible to provide new equipment and manufacturer-backed warranties. If proposing a domestic alternative: Technical evidence proving equivalent transfection performance and workflow continuity with existing NICHD mammalian cell protocols without requiring experimental re-validation. 6. Rough Order of Magnitude (ROM) Pricing (Optional): Non-binding budgetary pricing estimate for market research purposes. 5. Place of Performance: NIH, 9000 Rockville Pike, Bethesda, MD 20892 6. Submission Deadline and Contact Information Please submit electronic Capability Statements in PDF or Microsoft Word format via email to Tina Robinson at robinsti@mail.nih.gov no later than November 18, 2026, at 11:00 AM EST. Telephone inquiries will not be accepted. Capability Statements must reference Notice Number 75N98027R00019. Email submissions and any questions must be sent to robinsti@mail.nih.gov and include Notice Number 75N98027R00019 in the subject line. Capability Statements and attachments will not be returned to the sender. This synopsis is for information and planning purposes only and shall not be construed as a commitment by the Government, nor will the Government pay for information solicited. | 40% | Market Research | 11/18/2026 |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the laboratory. It will replace the current Illumina MiSeq instruments in the lab that were purchased in 2021 and 2022. The vendor will discontinue service on the current model of the MiSeq. New instruments are required to ensure time to validate these replacements before discontinuation of service. The total dollar value for this order is $139,100.52. The MiSeq is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run. The MiSeq provides the Lab with the highest HLA typing results possible. The transplant protocols served by the HLA Lab require highest resolution possible to increase the chance of a successful transplant. The HLA Lab currently owns two MiSeq instruments, so the procedures and Quality Control assessments are in place. The order aims to replace the Illumina Miseq – s/n M07700 (property ID is 02223449) and s/n M08636 (property ID is 02268689) that were purchased in 2019 and 2022. Replacement is necessary to ensure proper performance of these instruments prior to discontinuation of service for the current model of the Illumina MiSeq instruments by the vendor. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000836) by 12:00 PM eastern standard time on 11/27/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | 38% | Pre-Solicitation | 11/27/2026 |
Additional Details
Solicitation Number
NICHD-23-234
Archive Date
Jul 26, 2023
Office Address
BETHESDA, MD, 20817